Helicon Health® receive funding from the SBRI
Published on 25 May 2017
Helicon Health®, a UCL spinout company supported by UCL Business, has recently received funding from the Small Business Research Initiative Healthcare programme, with a share of the £2.1m investment in innovation to build General Practice (GP) services of the future. The investment is funded by NHS England and Helicon is one of a group of companies selected to develop novel technologies that aim to improve primary care and GP services.
Helicon Health® will use this funding to develop myHelicon-StrokePrevent™, an easy-to use app and digital platform for patients who are at risk of a stroke, to help them become confident in self-care, reduce risk, and to live longer healthier lives.
MyHelicon – StrokePrevent™ represents the next step in the continuation of the successful commercial development of the company to deliver patient powered self-care solutions to unlock benefits for the NHS patients and GPs.
“Stroke is a terrible injury caused by a clot or bleed in the brain. It can result in death or permanent disability. I am delighted Helicon has been selected for this award, to help reduce the burden of stroke to individuals, their families and the NHS”, said Professor David Patterson, Helicon’s founder and Chief Medical Officer.
“This SBRI healthcare award is a great reflection on Helicon Health and their unique myHelicon-StrokePrevent™ app and digital platform. We look forward to continuing supporting the company’s ongoing growth and product development” Commented Cengiz Tarhan, Managing Director of UCLB.
About UCL Business PLC
UCL Business PLC (UCLB) is a leading technology transfer company that supports and commercialises research and innovations arising from UCL, one of the UK’s top research-led universities. UCLB has a successful track record and a strong reputation for identifying and protecting promising new technologies and innovations from UCL academics. UCLB has a strong track record in commercialising medical technologies and provides technology transfer services to UCL’s associated hospitals; University College London Hospitals, Moorfields Eye Hospital, Great Ormond Street Hospital for Children and the Royal Free London Hospital. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from laboratory to market. For further information, please visit: www.uclb.com Twitter: @UCL_Business
About Helicon Health®
Helicon Health® is an award winning digital health spin out from UCL and the NHS. Helicon is pioneering the use of open source and open standards in Electronic Health Records and has embraced the new drugs, and IoT based diagnostic devices including apps; use of machine learning and wearables. Our Vision is “A healthy and proper lifespan” – “Avoiding watershed events such as strokes and heart attacks” Our Mission: “To deliver a digital platform for stroke prevention, for healthcare systems and direct to people” “Once proven, to apply the platform to other conditions” For further information, please visit: www.heliconhealth.co.uk Twitter: @Heliconhealth
Print friendly version of Helicon Health® receive funding from the SBRI